Results 181 to 190 of about 36,160 (268)

Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations. [PDF]

Can Commun Dis Rep
Simmons AE, Ximenes R, Gebretekle GB, Salvadori MI, Wong E, Tuite AR.   +5 more
europepmc   +1 more source

Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis. [PDF]

NPJ Vaccines
Wagner G, Gartlehner G, Thaler K, Ledinger D, Feyertag J, Klerings I, Saif-Ur-Rahman KM, Devane D, Olsson K, Adel Ali K, Vygen-Bonnet S, Salo H, Zavadska D, Grgič Vitek M, Oona M, Cunney R, Tuerlinckx D, Kristensen Lomholt F, Sommer I.   +18 more
europepmc   +1 more source

Changing Landscape of Invasive Pneumococcal Disease Serotypes and Antimicrobial Resistance Following Pneumococcal Conjugate Vaccine Introduction in the Middle East and North Africa Region: A Systematic Review. [PDF]

Vaccines (Basel)
El Zein Z, Nasser M, Boutros CF, Tfaily N, Reslan L, Faour K, Merhi S, Damaj S, Moumneh MB, Bou Dargham T, Youssef N, Haj M, Bou Karroum S, Khafaja S, Assaf Casals A, Chamseddine S, Hneiny L, Dbaibo GS.   +17 more
europepmc   +1 more source

Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme. [PDF]

Infect Dis Ther
Çakar E, Ta A, Peters M, Vinand E, Waterval-Overbeek A, Ilic A, Perdrizet J.   +6 more
europepmc   +1 more source

Pneumococcal conjugate vaccine and pneumococcal common protein vaccines

, 2013
Keith P. Klugman, Steven Black, Ron Dagan, Richard Malley, Cynthia G. Whitney   +4 more
openaire   +1 more source

Effects of COVID-19 and pneumococcal conjugate vaccines on hospitalized older COVID-19 patients in Türkiye

Güzin Zeren Öztürk, İlknur Demir, Zeynep Beşışık Yılmaz   +2 more
openalex   +1 more source

Correction to: Radiographically confirmed pneumonia in Malawian children and associated Pneumococcal carriage after introduction of the 13-valent Pneumococcal conjugate vaccine. [PDF]

Pneumonia (Nathan)
Mzumara G, Chirombo J, D Swarthout T, Bar-Zeev N, Prisca Harawa P, Sanusi Jalloh M, Kirolos A, Mukhula V, Newberry L, Ogunlade O, Wachepa R, French N, S Heyderman R, Iroh Tam PY.   +13 more
europepmc   +1 more source

Long-term impact of 10-valent pneumococcal conjugate vaccine among children <5 years, Uganda, 2014-2021. [PDF]

PLOS Glob Public Health
Wanyana MW, Migisha R, King P, Bulage L, Kwesiga B, Kadobera D, Ario AR, Harris JR.   +7 more
europepmc   +1 more source

A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host [PDF]

, 2019
Chavez, Sthefany M., Feldman, Mario F., Huynh, Jeremy P., Kinsella, Rachel L., Mayer, Anne E., Stallings, Christina L.   +5 more
core   +1 more source